No Data
No Data
RBC Capital Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Cuts Target Price to $4.29
Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript Summary
Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript
Maxim Group Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5
H.C. Wainwright Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5
CCORF Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Maintains Target Price $5
No Data